Alan E. Wakeling

4.7k total citations
44 papers, 3.1k citations indexed

About

Alan E. Wakeling is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Alan E. Wakeling has authored 44 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 20 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Alan E. Wakeling's work include Estrogen and related hormone effects (28 papers), HER2/EGFR in Cancer Research (15 papers) and Inflammatory mediators and NSAID effects (7 papers). Alan E. Wakeling is often cited by papers focused on Estrogen and related hormone effects (28 papers), HER2/EGFR in Cancer Research (15 papers) and Inflammatory mediators and NSAID effects (7 papers). Alan E. Wakeling collaborates with scholars based in United Kingdom, United States and Australia. Alan E. Wakeling's co-authors include Jean Bowler, Robert I. Nicholson, Denise Barrow, Julia M.W. Gee, Anthony Howell, Charles Morris, C. Kent Osborne, Iain R. Hutcheson, Janice M. Knowlden and Tracie‐Ann Madden and has published in prestigious journals such as Science, Journal of Biological Chemistry and Cancer.

In The Last Decade

Alan E. Wakeling

43 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan E. Wakeling United Kingdom 26 1.6k 1.5k 1.2k 458 412 44 3.1k
Michael Dukes United Kingdom 11 981 0.6× 1.1k 0.7× 902 0.7× 449 1.0× 514 1.2× 14 2.5k
Anne E. Lykkesfeldt Denmark 39 1.4k 0.9× 1.8k 1.3× 1.4k 1.2× 803 1.8× 408 1.0× 111 3.5k
Karen Huff United States 29 2.1k 1.3× 1.7k 1.2× 1.4k 1.2× 865 1.9× 209 0.5× 42 3.9k
Sophie Dauvois Canada 20 2.2k 1.4× 1.8k 1.2× 729 0.6× 288 0.6× 266 0.6× 26 3.0k
Yoko Omoto Japan 29 1.2k 0.7× 1.1k 0.8× 870 0.7× 553 1.2× 353 0.9× 49 2.5k
John D. Norris United States 35 2.8k 1.7× 2.7k 1.8× 1.0k 0.8× 571 1.2× 710 1.7× 60 5.0k
Shin‐ichi Hayashi Japan 37 1.3k 0.8× 3.0k 2.0× 1.4k 1.1× 848 1.9× 538 1.3× 91 4.9k
Yolande Berthois France 21 1.2k 0.7× 1.2k 0.8× 737 0.6× 366 0.8× 115 0.3× 54 2.5k
Jonna Frasor United States 33 1.9k 1.2× 2.2k 1.5× 1.3k 1.1× 814 1.8× 236 0.6× 71 4.1k
Ching‐yi Chang United States 37 1.8k 1.2× 2.5k 1.7× 785 0.6× 1.2k 2.6× 710 1.7× 69 4.8k

Countries citing papers authored by Alan E. Wakeling

Since Specialization
Citations

This map shows the geographic impact of Alan E. Wakeling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan E. Wakeling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan E. Wakeling more than expected).

Fields of papers citing papers by Alan E. Wakeling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan E. Wakeling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan E. Wakeling. The network helps show where Alan E. Wakeling may publish in the future.

Co-authorship network of co-authors of Alan E. Wakeling

This figure shows the co-authorship network connecting the top 25 collaborators of Alan E. Wakeling. A scholar is included among the top collaborators of Alan E. Wakeling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan E. Wakeling. Alan E. Wakeling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Massarweh, Suleiman, C. Kent Osborne, Alan E. Wakeling, et al.. (2006). Mechanisms of Tumor Regression and Resistance to Estrogen Deprivation and Fulvestrant in a Model of Estrogen Receptor–Positive, HER-2/neu-Positive Breast Cancer. Cancer Research. 66(16). 8266–8273. 115 indexed citations
2.
Hiscox, Stephen, L. Morgan, Denise Barrow, et al.. (2004). Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: Inhibition by gefitinib (`Iressa', ZD1839). Clinical & Experimental Metastasis. 21(3). 201–212. 93 indexed citations
3.
Hutcheson, Iain R., Janice M. Knowlden, Tracie‐Ann Madden, et al.. (2003). Oestrogen Receptor-Mediated Modulation of the EGFR/MAPK Pathway in Tamoxifen-Resistant MCF-7 Cells. Breast Cancer Research and Treatment. 81(1). 81–93. 138 indexed citations
4.
Knowlden, Janice M., Iain R. Hutcheson, Helen E. Jones, et al.. (2003). Elevated Levels of Epidermal Growth Factor Receptor/c-erbB2 Heterodimers Mediate an Autocrine Growth Regulatory Pathway in Tamoxifen-Resistant MCF-7 Cells. Endocrinology. 144(3). 1032–1044. 432 indexed citations
5.
Barton, Jeremy, G. Blackledge, & Alan E. Wakeling. (2001). Growth factors and their receptors: new targets for prostate cancer therapy. Urology. 58(2). 114–122. 92 indexed citations
6.
Howell, Anthony, C. Kent Osborne, Charles Morris, & Alan E. Wakeling. (2000). ICI 182,780 (Faslodex?). Cancer. 89(4). 817–825. 338 indexed citations
7.
Jones, Helen, Carol M. Dutkowski, Denise Barrow, et al.. (1997). New EGF‐R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC‐3 and DU‐145. International Journal of Cancer. 71(6). 1010–1018. 2 indexed citations
8.
Parisot, John P., et al.. (1995). The pure antiestrogen ICI 182,780 binds to a high‐affinity site distinct from the estrogen receptor. International Journal of Cancer. 62(4). 480–484. 32 indexed citations
9.
Wilson, James W., Alan E. Wakeling, Ian D. Morris, John A. Hickman, & Caroline Dive. (1995). MCF‐7 human mammary adenocarcinoma cell death in vitro in response to hormone‐withdrawal and dna damage. International Journal of Cancer. 61(4). 502–508. 44 indexed citations
10.
Osborne, C. Kent, Michael Jarman, R. MCCAGUE, et al.. (1994). The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth. Cancer Chemotherapy and Pharmacology. 34(2). 89–95. 98 indexed citations
11.
Zalcberg, John, Xiu Feng Hu, Michael S. Ching, et al.. (1993). Differential effects of estrogen, tamoxifen and the pure antiestrogen ICI 182,780 in human drug-resistant leukemia cell lines. Cancer Chemotherapy and Pharmacology. 33(2). 123–129. 13 indexed citations
12.
Wakeling, Alan E.. (1993). The future of new pure antiestrogens in clinical breast cancer. Breast Cancer Research and Treatment. 25(1). 1–9. 111 indexed citations
13.
Wiseman, Lynda R., Michael D. Johnson, Alan E. Wakeling, et al.. (1993). Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells. European Journal of Cancer. 29(16). 2256–2264. 71 indexed citations
14.
Brünner, Nils, Thomas Leth Frandsen, Claus Holst‐Hansen, et al.. (1993). MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780.. PubMed. 53(14). 3229–32. 94 indexed citations
15.
Wakeling, Alan E. & Jean Bowler. (1992). ICI 182,780, a new antioestrogen with clinical potential. The Journal of Steroid Biochemistry and Molecular Biology. 43(1-3). 173–177. 216 indexed citations
16.
Wiseman, Lynda R., Alan E. Wakeling, Felicity E. B. May, & Bruce R. Westley. (1989). Effects of the antioestrogen, ICI 164,384, on oestrogen induced RNAs in MCF-7 cells. Journal of Steroid Biochemistry. 33(1). 1–6. 24 indexed citations
17.
Bowler, Jean, et al.. (1989). Novel steroidal pure antiestrogens. Steroids. 54(1). 71–99. 159 indexed citations
18.
May, Felicity E. B., Michael D. Johnson, Lynda R. Wiseman, et al.. (1989). Regulation of progesterone receptor mRNA by oestradiol and antioestrogens in breast cancer cell lines. Journal of Steroid Biochemistry. 33(6). 1035–1041. 61 indexed citations
19.
Weatherill, Philip J., Anne Wilson, Robert I. Nicholson, Peter J. Davies, & Alan E. Wakeling. (1988). Interaction of the antioestrogen ICI 164,384 with the oestrogen receptor. Journal of Steroid Biochemistry. 30(1-6). 263–266. 59 indexed citations
20.
Wakeling, Alan E., K.T. Kirton, & Lillian J. Wyngarden. (1973). Prostaglandin receptors in the hamster uterus during the estrous cycle. Prostaglandins. 4(1). 1–8. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Dukes Breakdown of academic impact, for papers by Anne E. Lykkesfeldt Breakdown of academic impact, for papers by Karen Huff Breakdown of academic impact, for papers by Sophie Dauvois Breakdown of academic impact, for papers by Yoko Omoto Breakdown of academic impact, for papers by John D. Norris Breakdown of academic impact, for papers by Shin‐ichi Hayashi Breakdown of academic impact, for papers by Yolande Berthois Breakdown of academic impact, for papers by Jonna Frasor Breakdown of academic impact, for papers by Ching‐yi Chang
Rankless by CCL
2026